VIR — Vir Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Vir Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	708	2,402	1,522	905	467
Net Total Accounts Receivable
Net Total Receivables	773	0	—	5	3.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,563	2,519	1,588	1,042	514
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	130	188	167	123	118
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,954	2,802	1,919	1,399	1,003
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	341	511	175	120	92.8
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	522	724	329	248	238
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	1,432	2,078	1,590	1,150	765
Total Liabilities & Shareholders' Equity	1,954	2,802	1,919	1,399	1,003
Total Common Shares Outstanding